SE7412058L - - Google Patents

Info

Publication number
SE7412058L
SE7412058L SE7412058A SE7412058A SE7412058L SE 7412058 L SE7412058 L SE 7412058L SE 7412058 A SE7412058 A SE 7412058A SE 7412058 A SE7412058 A SE 7412058A SE 7412058 L SE7412058 L SE 7412058L
Authority
SE
Sweden
Prior art keywords
alpha
beta
pregnen
methylen
diones
Prior art date
Application number
SE7412058A
Other languages
Unknown language ( )
English (en)
Inventor
U Kerb
R Wiechert
L Alig
A Furst
M Muller
P Keller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7412058L publication Critical patent/SE7412058L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
SE7412058A 1973-09-26 1974-09-25 SE7412058L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
SE7412058L true SE7412058L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-03-27

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7412058A SE7412058L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-09-26 1974-09-25

Country Status (16)

Country Link
US (1) US3965128A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5059362A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR202946A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU7374074A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE820381A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD114599A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2349024A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK507974A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI280574A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2244492A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL45629A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU70985A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7412747A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO743449L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7412058L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA746131B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025703A1 (en) * 1997-11-14 1999-05-27 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
EP2332527A3 (en) * 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
NZ566180A (en) * 2005-07-29 2011-04-29 Resverlogix Corp Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
PL2118074T3 (pl) 2007-02-01 2014-06-30 Resverlogix Corp Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
KR101913109B1 (ko) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 신규한 소염제
HRP20182200T1 (hr) 2009-04-22 2019-03-22 Resverlogix Corp. Nova protuupalna sredstva
CA2851996C (en) 2011-11-01 2020-01-07 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． ブロモドメイン阻害剤としての新規複素環式化合物
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Also Published As

Publication number Publication date
AU7374074A (en) 1976-04-01
FR2244492A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-18
BE820381A (fr) 1975-03-26
US3965128A (en) 1976-06-22
FI280574A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-03-27
DK507974A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-06-09
DD114599A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-12
NL7412747A (nl) 1975-04-01
ZA746131B (en) 1975-09-24
LU70985A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-03-06
NO743449L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-04-28
IL45629A0 (en) 1974-11-29
AR202946A1 (es) 1975-07-31
JPS5059362A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-22
DE2349024A1 (de) 1975-04-10

Similar Documents

Publication Publication Date Title
SE7412058L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA1030951A (en) 1,3-OXYGENATED 8.alpha.-OESTRATRIENES
SE7415592L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA1030950A (en) 1,3-OXYGENATED 8.alpha.-OESTRATRIENES
CA1034572A (en) 6-NOR-6-ALKYL-9,10-DIHYDRO-2'.beta.-METHYL-5'.alpha.-BENZYL-ERGOPEPTINE
CA1033716A (en) 17.beta.-HYDROXY-16,16-DIMETHYLESTR-4-EN-3-ONE
CA963000A (en) 15.alpha.,16.alpha.-METHYLENE-STEROIDS
ZA717774B (en) New 6alpha-fluoro-16alpha,18-dimethyl-delta 1,4-pregnadiene-3,20-diones
CA942295A (en) PROCESS FOR THE MANUFACTURE OF PREGNAN-20-ONE-3.beta.,5.beta.,14.beta.,21-TETROL
CA913613A (en) 11,21-BIS-OXYGENATED-17.alpha.-HYDROXY-16.beta.-METHYL-STEROID-3,20-DIONES
CA857868A (en) 17-HYDROXY- AND 17-ACYLOXY-6.beta.,7.beta.-EPOXY-1.alpha.,2.alpha.-METHYLENE-4-PREGNENE-3,20-DIONES
CA893110A (en) 3,20-DIOXO 16.alpha.,17.alpha.-DIHYDROXY 19-NOR PREGNA-4-ENE
CA843408A (en) 1,4-pregnadiene from biological dehydrogenation
CA972350A (en) 1,2-METHYLENE-17.alpha.-ACYLOXY(OR IMPROVED HYDROXY)-9.beta.,10.alpha.-STEROID COMPOUNDS OF THE PREGNANE SERIES, PHARMACEUTIC PREPARATIONS OF THE BASIS OF THE NOVEL COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS AND PREPARATIONS
CA850657A (en) 2,3-dihydro-1,4-benzoxazines
CA866780A (en) 9.beta.,10.alpha. STEROIDS
CA861501A (en) 6-METHYL-9.beta., 11.beta.-OXIDO-16.alpha.,17.alpha.-21-TRIHYDROXY STEROIDS
CA839251A (en) 4-OXA-9.beta.,10.alpha.-STEROIDS
CA882103A (en) 11.beta.-HYDROXY-5.alpha.,6.alpha.-EPOXYSTEROIDE
CA866779A (en) 9.beta.,10.alpha.-STEROID
CA851705A (en) 9.beta.,10.alpha.-STEROIDS AND PROCESS FOR THE MANUFACTURE THEREOF
CA850088A (en) 9.beta.,10.alpha.-STEROIDS AND PROCESS FOR THE MANUFACTURE THEREOF
NZ182865A (en) 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones
CA863337A (en) .DELTA.1,4-PREGNADIENE-17.alpha.,21-DIOL-3,11,20-TRIONE
CA900971A (en) PROCESS FOR THE PREPARATION OF 17.alpha.-MONOESTERS OF 11.beta., 17.alpha., 21-TRIHYDROXYSTEROIDS

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7412058-5

Format of ref document f/p: F